These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18524891)

  • 61. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1.
    Li R; Li G; Deng L; Liu Q; Dai J; Shen J; Zhang J
    Oncol Rep; 2010 Jun; 23(6):1553-9. PubMed ID: 20428809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.
    Liu Q; Li G; Li R; Shen J; He Q; Deng L; Zhang C; Zhang J
    J Neurooncol; 2010 Nov; 100(2):165-76. PubMed ID: 20361349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
    Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
    Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
    Zhang N; Duan WD; Leng JJ; Zhou L; Wang X; Xu YZ; Wang XD; Zhang AQ; Dong JH
    Oncol Rep; 2015 Mar; 33(3):1493-8. PubMed ID: 25571964
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PTEN-deficient cancers depend on PIK3CB.
    Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ.
    Chen CL; Chiang TH; Tseng PC; Wang YC; Lin CF
    Biochem Biophys Res Commun; 2015 Oct; 466(3):578-84. PubMed ID: 26385178
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
    Heering J; Erlmann P; Olayioye MA
    Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PTEN overexpression promotes glioblastoma death through triggering mitochondrial division and inactivating the Akt pathway.
    Bao L; Li X; Lin Z
    J Recept Signal Transduct Res; 2019 Jun; 39(3):215-225. PubMed ID: 31464538
    [No Abstract]   [Full Text] [Related]  

  • 69. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
    Hong L; Ya-Wei L; Hai W; Qiang Z; Jun-Jie L; Huang A; Song-Tao Q; Yun-Tao L
    J Neurooncol; 2016 May; 128(1):35-45. PubMed ID: 26970980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
    Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
    Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
    Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
    Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
    Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
    J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.
    Chen LY; Wang X; Qu XL; Pan LN; Wang ZY; Lu YH; Hu HY
    J Cell Physiol; 2019 Nov; 234(11):19640-19654. PubMed ID: 30950039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
    Zhao D; Chen Y; Chen S; Zheng C; Hu J; Luo S
    Tumour Biol; 2017 May; 39(5):1010428317705341. PubMed ID: 28475001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PTEN inhibits AMPK to control collective migration.
    Peglion F; Capuana L; Perfettini I; Boucontet L; Braithwaite B; Colucci-Guyon E; Quissac E; Forsberg-Nilsson K; Llense F; Etienne-Manneville S
    Nat Commun; 2022 Aug; 13(1):4528. PubMed ID: 35953476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PTEN functions as a melanoma tumor suppressor by promoting host immune response.
    Dong Y; Richards JA; Gupta R; Aung PP; Emley A; Kluger Y; Dogra SK; Mahalingam M; Wajapeyee N
    Oncogene; 2014 Sep; 33(38):4632-42. PubMed ID: 24141770
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PIP4K2A as a negative regulator of PI3K in PTEN
    Shin YJ; Sa JK; Lee Y; Kim D; Chang N; Cho HJ; Son M; Oh MYT; Shin K; Lee JK; Park J; Jo YK; Kim M; Paddison PJ; Tergaonkar V; Lee J; Nam DH
    J Exp Med; 2019 May; 216(5):1120-1134. PubMed ID: 30898893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.